Clinical protocol amendment approval workflow
This clinical protocol amendment approval workflow maps the controlled release of a revised study protocol. The process begins with quality review, returns incomplete packages for correction, and routes subject-risk changes to an IRB or ethics review. Medical review and any required regulatory filing occur before the approved version is released to trial sites.
Open it in the AI editor with a prompt pre-filled — keep what works, change what doesn't.
Scenario
A study sponsor is controlling a protocol amendment before investigators use it at clinical trial sites.
Key decisions
- Quality review catches incomplete amendment packages.
- Subject-risk changes receive IRB or ethics review.
- Medical monitor acceptance remains required after ethics review.
- A regulatory filing is conditional on the amendment.
- Sites are trained only after the approved version is released.
When to reuse this
This is a generic control-flow example for clinical research. Actual ethics and regulatory requirements depend on jurisdiction, protocol, sponsor, and study phase.
Frequently asked questions
When is ethics review needed?
Why train sites after release?
Does every amendment require a regulatory filing?
Tweak it with chat, export PNG/SVG, or fork it for your own use case.